Navigation Links
Arena Pharmaceuticals' Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
Date:10/12/2009

SAN DIEGO, Oct. 12, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that lorcaserin will be featured in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC.

The line-up includes a late-breaking abstract oral presentation of results from BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management), a Phase 3 trial for which Arena reported positive, highly significant top-line results in September. Arena will also present new data analyses from lorcaserin's successful Phase 3 pivotal program in oral and poster sessions. In an independent clinical symposium, expert academic scientists and physicians will spotlight the 5HT-2C mechanism for weight management.

The positive results from our Phase 3 pivotal program highlight lorcaserin's potential to provide physicians with a treatment option that combines three important attributes - efficacy, safety and tolerability

"- critical to broad applicability in the majority of their patients to help manage weight and improve cardiometabolic health," stated William R. Shanahan, M.D., Arena's Vice President and Chief Medical Officer. "The breadth of presentations featuring lorcaserin at The Obesity Society's annual scientific meeting speaks to the strong interest physicians have in this drug candidate."

Obesity 2009: Presentation Schedule

    Saturday, October 24, 2009

        -- Pre-Conference Session: Pharmacotherapy Update
           Time: 1:00 - 3:45 p.m. Eastern Time (ET)
           Chairs: Ken Fujioka, M.D., Louis J. Aronne, M.D., and Richard
            Pratley, M.D.
           Presenter: Christen M. Anderson, M.D., Ph.D.

    Sunday, October 25, 2009

        -- Poster Session
           Time: on display 1:00 -
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23 2014 Ampio Pharmaceuticals, Inc. ... new headquarters, manufacturing and research facility: Ampio ... 80112 Direct: (720) 437-6500 Michael ... pharmaceutical drug manufacturing facility will be fully operational this ... first batches of Ampion TM necessary to accommodate ...
(Date:7/23/2014)... , July 23, 2014  ArmaGen, a ... therapies to treat severe neurological disorders, announced today ... and collaboration agreement with Shire plc to develop ... potential treatment of both the central nervous system ... Also known as MPS II, Hunter syndrome is ...
(Date:7/22/2014)... July 23, 2014   - Investment ... Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a fully-fledged oncology pharmaceutical ... be investing US$30 million in Remiges BioPharma Fund (hereinafter ... Taiho has a long history of developing ... and cancer patients. Our development of TAS-102 is an ...
Breaking Medicine Technology:Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP 2
... September 9, 2011 The Board of the ... today it agreed to ratify the proposal of the US ... package, designed with the help of EFCG and US industry ... User Fees Act (GDUFA). GDUFA requires the FDA ...
... Advanced Wound Management division of Smith & Nephew (LSE: SN; ... studies on a range of products and therapies from their ... RENASYS* wound care portfolio. The data demonstrate advanced healing strategies ... products. Results of the studies are being presented at the ...
Cached Medicine Technology:European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA) 2Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference 2Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference 3Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference 4
(Date:7/23/2014)... July 23, 2014 Low enrollment ... insurance exchanges to come up with alternative means ... the myriad ways to accomplish this in the ... Health Insurance Exchanges (HEX). , “We never expected ... state-run exchanges, Christopher Condeluci, an attorney at the ...
(Date:7/23/2014)... Hills, CA (PRWEB) July 23, 2014 ... 90 million Americans suffering from chronic bad breath that the ... whom they speak. , Dr. Saj Jivraj and Dr. Mamaly ... Woodland Hills, Calif., are concerned that some people may be ... breath often is a sign of an infection or chronic ...
(Date:7/23/2014)... 2014 On July 19 and 20, the ... NBC 4 New York and New York Giants Health & ... , The team, which included several hearing healthcare ... free hearing health screenings and answered any questions that attendees ... technology. , Also sponsored by the NFL Players Association, ...
(Date:7/23/2014)... TeraGanix has recently announced the opening ... only 4.5 miles off of highway I-8. The new production ... for businesses in the Arizona region that use its popular ... Casa Grande location is only 1 hour away from Tucson, ... Phoenix. With over 26 million acres of agricultural land ...
(Date:7/23/2014)... Seattle, Wa (PRWEB) July 23, 2014 ... body sweats, it means that it is healthy enough ... is also useful for “washing out” harmful toxins and ... excretory system of the body just cannot do. ... prone to hyperhidrosis—or more commonly known as “excessive sweating”—are ...
Breaking Medicine News(10 mins):Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 3Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 3Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 4Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 5Health News:The HearStrong Foundation Provides Hearing Healthcare Awareness at the NBC 4 New York and New York Giants Health & Fitness Expo 2014 2Health News:TeraGanix Opens New Arizona-Based Agricultural Products Supply Facility 2Health News:TeraGanix Opens New Arizona-Based Agricultural Products Supply Facility 3Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3
... of white rice weekly can up risk of type 2 diabetes, ... brown rice or another whole grain for white rice can help ... , Five or more servings of white rice a week increased ... the study, which is published in the June 14 issue of ...
... Doctors have long known that snoring is hazardous to ... restless nights and increased daytime sleepiness, sleep-disordered breathing (SDB) ... risk of cardiovascular disease (CVD). While it is not ... given health problem is, new research exposes that at ...
... Men with this history are more prone to hit and ... -- Men who attempted suicide before age 18 are much ... a study from the Oregon Social Learning Center in Eugene. ... neighborhoods who were assessed annually from ages 10 to 32. ...
... ... Site to Advance the Discussion, Innovations of Health Information Technology , ... Carrollton, GA (PRWEB) ... health record (EHR), practice management and interoperability solution PrimeSuite®, is today launching BlogEHR, ...
... JOLLA, Calif., June 15, 2010 Without knowing exactly ... take non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin have lower ... study appearing in Cancer Cell on June ... their colleagues have figured out how one NSAID, called ...
... ... Achieves a Smoother, Firmer Skin Surface , ... Los Angeles, Calif. (PRWEB) June 14, 2010 -- For ... problem areas and achieve a slimmer, smoother and firmer appearance. However, the procedure is ...
Cached Medicine News:Health News:Brown Rice Bests White for Diabetes Prevention 2Health News:Brown Rice Bests White for Diabetes Prevention 3Health News:Possible link between sleep-disordered breathing and cardiovascular disease revealed 2Health News:Teen Boys Who Attempt Suicide More Likely to Abuse as Adults 2Health News:Industry Leaders Featured in Greenway's BlogEHR 2Health News:Industry Leaders Featured in Greenway's BlogEHR 3Health News:Turning a painkiller into a cancer killer 2Health News:Why More Women are Choosing OptiLipo over Liposuction 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: